Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Status and Novel Perspectives

SIMPLE SUMMARY: Immune checkpoint inhibitors represent a promising treatment choice in many kind of tumours, including hepatocellular carcinoma (HCC). In this review, we provide an overview of the role of these new agents in the management of HCC according to the Barcelona staging system, alongside...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancers (Basel)
Asıl Yazarlar: Federico, Piera, Petrillo, Angelica, Giordano, Pasqualina, Bosso, Davide, Fabbrocini, Antonietta, Ottaviano, Margaret, Rosanova, Mario, Silvestri, Antonia, Tufo, Andrea, Cozzolino, Antonio, Daniele, Bruno
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2020
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7603151/
https://ncbi.nlm.nih.gov/pubmed/33080958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12103025
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller